NCT03262844

Brief Summary

Background: Tethered cord syndrome (TCS) is a progressive clinical condition including a series of neurological dysfunctions and deformities attributable to abnormally increased tension on the spinal cord, which is lacking effective treatment to relieve the symptoms and prevent progression. Dr. Shi recently proposed a new technique as nerve root axial decompression surgery, which is also called capsule surgery, to treat patients with TCS. Yet, the effectiveness and safety should be further studied. Purpose: The aim of this study is to compare the effectiveness and safety of clinical outcomes between capsule surgery and conservative treatment in patients with TCS. A study hypothesis is that outcomes will be improved after capsule surgery. Methods: This study is a randomized clinical trial with a two-factor (2x7) research design. The TCS patients will be randomly assigned in one of the two treatment groups: capsule surgery and conservative treatment. Seven outcome measures will be collected pre-operative for baseline, and then at1, 12, 24, 48, and 96 weeks post-operative follow-up visits, including: International Consultation on Incontinence Modular Questionnaire Short Version (ICI-Q-SF), Rintala Score, a new developed Chinese version of questionnaire, Oswestry disability index (ODI), SF-12, foot function index (FFI) and Pirani score. Urodynamic testing, bladder ultrasonography, electromyogram, muscle strength and sensation of lower limbs will be obtained before and post treatment, to determine the patient's function of lower limbs. The investigator performing the outcome measures will be blinded to group assignment, and therefore will not participate in treatment. After randomization, the conservative group will be followed up in the outpatient clinic. The capsule surgery group will receive the nerve root axial decompression surgery (capsule surgery). Data Analysis: Two 2x7 MANOVAs with repeated measures will be used to examine the differences in the seven measures between groups and at the five different time frames with the α level set at 0.05. Non-parametric tests (Mann-Whitney U tests) will be used to compare the differences in the urodynamics and muscle strength data over time and between groups.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 16, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 6, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

August 25, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

September 27, 2018

Status Verified

September 1, 2018

Enrollment Period

1.8 years

First QC Date

August 6, 2017

Last Update Submit

September 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes of patient-reported scores assessing bladder function

    International Consultation on Incontinence Modular Questionnaire Short Version (ICI-Q-SF) is used to assess urinary function and the impacts on patient's quality of life due to urinary problems.

    At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

Secondary Outcomes (8)

  • Changes of patient-reported scores assessing bowel function

    At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  • Changes of patient-reported quality of life due to bladder dysfuction

    At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  • Bladder function

    At 1 week pre- and 1, 12, 48, and 96 weeks post-operative follow-up visits.

  • Muscle power

    At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  • Improvment of clubfoot deformity

    At 1 week pre- and 1, 12, 24, 48, and 96 weeks post-operative follow-up visits.

  • +3 more secondary outcomes

Study Arms (2)

Conservative treatment

PLACEBO COMPARATOR

Conservative physiotherapy, intermittent catheterization, or drug treatment for bladder or bowel dysfunction

Behavioral: Conservative treatment

Capsule surgery

EXPERIMENTAL

Nerve root axial decompression surgery (Capsule surgery)

Procedure: Capsule surgery

Interventions

The conservative treatment group will be given diet and nursing guidance, then the drug treatment or physiotherapy will be given according to the conditions of patients. Patients with bladder dysfunction will be guided to perform routine intermittent catheterization with help of their parents.

Conservative treatment

In the multiple segments of the spine, articular facet joint and intervertebral disc will be resected to achieve the effect of decompression. Specific surgical segments, osteotomy range, decompression degree of each patient needs to be designed individually.

Capsule surgery

Eligibility Criteria

Age14 Years - 20 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patients aged 14-20 years, without gender limitation, are willing to sign informed consent;
  • patients diagnosed with tethered cord syndrome (TCS);
  • patients accepted untethering surgery or resection of intra-lipomas or myelomeningocele after birth;
  • patients present with the recent occurrence of bladder or bowel dysfunction, with progressive deterioration, may be accompanied by motor deficits of lower extremity;
  • urodynamic examination suggests neurogenic injury;
  • the current conventional treatment is difficult to achieve satisfactory clinical outcomes.

You may not qualify if:

  • bladder or ureter obstruction;
  • other types of neurogenic bladder dysfunction (spinal cord injury, cerebral palsy, other brain injuries);
  • anorectal malformations;
  • poor health condition, unable to tolerate surgery;
  • patients (or their guardians) cannot give full informed consent for cognitive dysfunction;
  • patients who have participated in other clinical trials in the past 1 month.
  • patients with active hepatitis B (including HBeAg) or serological markers (HBsAg or / and HBeAg or / and HBcAb), hepatitis C, tuberculosis, cytomegalovirus infection, severe fungal infection or HIV infection;
  • patients with active peptic ulcers within 3 months before randomization.
  • patients with malignant neoplasms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Changzheng Hospital

Shanghai, Shanghai Municipality, 200001, China

RECRUITING

Related Publications (1)

  • Steinbok P, MacNeily AE, Hengel AR, Afshar K, Landgraf JM, Hader W, Pugh J. Filum Section for Urinary Incontinence in Children with Occult Tethered Cord Syndrome: A Randomized, Controlled Pilot Study. J Urol. 2016 Apr;195(4 Pt 2):1183-8. doi: 10.1016/j.juro.2015.09.082. Epub 2016 Feb 28.

    PMID: 26926544BACKGROUND

MeSH Terms

Conditions

Neural Tube Defects

Interventions

Conservative TreatmentSurgical Procedures, Operative

Condition Hierarchy (Ancestors)

Nervous System MalformationsNervous System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Jiangang Shi, MD

    Shanghai Changzheng Hospital, Second Military Medical University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The statistical analysist do not know the group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of No.2 department of spinal surgery

Study Record Dates

First Submitted

August 6, 2017

First Posted

August 25, 2017

Study Start

June 16, 2017

Primary Completion

April 1, 2019

Study Completion

April 1, 2020

Last Updated

September 27, 2018

Record last verified: 2018-09

Locations